Nova Eye Medical Ltd (ASX:EYE)
A$ 0.15 -0.0050 (-3.23%) Market Cap: 42.73 Mil Enterprise Value: 42.90 Mil PE Ratio: 0 PB Ratio: 2.68 GF Score: 43/100

Q4 2026 Nova Eye Medical Ltd Activities Report Presentation Transcript

Aug 3, 2026 / 01:30 AM GMT
Release Date Price: A$0.14 (+7.69%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EYE.AX - Nova Eye Medical Ltd
Q4 2026 Nova Eye Medical Ltd Activities Report Presentation
Aug 04, 2026 / 01:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Also, we'll provide some outlook on FY27. Presenting as always today is Tom Spirling, our Managing Director.

Again, Q&A available. If you look inside Zoom Q&A function, we'll look to get to as many questions as possible.

Also, we can follow-up post the webinar, but I will ask a number of questions, so please place them in the Q&A function within Zoom.

As we can see from the recent results, Tom's led the company through a wonderful four consecutive years of sales growth above 25%, and our FY26 closed at just below US $24 million, up 26%. And the second-half delivered the company's first positive EBITDA as guided by Tom and the team.

So Tom will take you through these
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot